PHASE IB/II CLINICAL TRIAL OF ALPELISIB AND TUCATINIB IN PATIENTS WITH PIK3CA-MUTANT HER2-POSITIVE METASTATIC BREAST CANCER

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Scope

National

Locations

CTRC Inpatient
University of Colorado Hospital

Principal Investigator
Photograph of Elena Shagisultanova,  MD, PhD

Elena Shagisultanova, MD, PhD

Study ID

Protocol Number: 21-5033

More information available at ClinicalTrials.gov: NCT05230810

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers